Reneo Pharmaceuticals’ Common Stock Offering

Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents.Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 6,875,000…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here